Davi Pereira de Santana

Davi Pereira de Santana

Auto-generated profile, based on publicly available information

Davi Pereira de Santana

Universidade Federal de Pernambuco

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2018 in Cosmetics
Verified
Journal Article
Open access
PDF file
GSGiovana Sousa
Giovana Sousa
IDIsabelle Moura Fittipaldi De Souza Dantas
Isabelle Moura Fittipaldi De Souza Dantas
DSDavi Pereira De Santana
Davi Pereira De Santana
Leila LealLeila Leal
Leila Leal
The aim of this study was to design new cosmetic formulations containing oils from catolé, licuri and spent coffee grounds, and to evaluate their immediate and long-term effects on skin barrier function and skin hydration. Nonionic oil-in-water (o/w) emulsions were prepared and physicochemically characterized. The effects of the formulations were assessed by volunteers and by measuring the water content of the epidermis (WCE) and transepidermal water loss (TEWL) both two hours and 20 days after daily application. The irritation potential was evaluated using three different methods: the Hen’s egg chorioallantoic membrane test (HET-CAM); the observation of undesirable effects after skin formulation application, and by using the L*a*b* system to verify changes in skin coloring. The results obtained showed that the formulations containing 10% of these oils presented promising characteristics in the improvement of hydration and skin barrier function when compared to the baseline values and with the placebo cream. According to the sensory evaluation performed, all creams were found to have great acceptability.

1 March 2004 in Revista Brasileira de Ciências Farmacêuticas
Verified
Journal Article
Open access
PDF file
ALAna Amélia Moreira Lira
Ana Amélia Moreira Lira
ESElizângela de Araújo Sester
Elizângela de Araújo Sester
LALuiz Renato Pires Abreu
Luiz Renato Pires Abreu
LSLeila Bastos Leal da Silva
Leila Bastos Leal da Silva
AWAlmir Gonçalves Wanderley
Almir Gonçalves Wanderley
DSDavi Pereira de Santana
Davi Pereira de Santana
O objetivo do presente estudo foi desenvolver formulações geleificadas do lapachol, substância de conhecida atividade antiinflamatória. Para otimização das formulações, foi verificada a influência da resina de Carbopol® empregada (934P, 940 e 941), do pH da formulação (5, 7 e 8), da concentração do princípio ativo (0,2%, 0,5% e 1,0%) bem como da incorporação de um promotor de absorção (Polissorbato 80) na liberação in vitro do lapachol utilizando células de difusão tipo Franz. Para tanto foram usadas como barreiras membrana sintética Durapore® e pele de rato albino tipo Wistar. Os resultados demonstraram que a adição do Polissorbato 80 na formulação promoveu aumento significativo na permeação do princípio ativo através da pele estudada, exceto para os géis contendo 0,2% de lapachol utilizando Carbopol® 934P como agente geleificante. Estes géis apresentaram as melhores taxas difusionais de lapachol, principalmente quando incorporados em formulações com pH 8, nas concentrações de 0,5% ou 1,0% de princípio ativo. Todavia as preparações contendo 1,0 % de princípio ativo apresentaram pequenos cristais de lapachol não solubilizados.

27 February 2020 in Revista Ibero-Americana de Ciências Ambientais
Verified
Journal Article
Open access
PDF file
MSMaria Carolina Silveira Costa Silva
Maria Carolina Silveira Costa Silva
HSHenrique Carlos Marinho Pereira da Silva
Henrique Carlos Marinho Pereira da Silva
KTKarla Patrícia de Sousa Barbosa Teixeira
Karla Patrícia de Sousa Barbosa Teixeira
DBDanilo Cesar Galindo Bedor
Danilo Cesar Galindo Bedor
Leila LealLeila Leal
Leila Leal
DSDavi Pereira de Santana
Davi Pereira de Santana
Brazil is the world’s largest consumer of pesticides and numerous studies have reported damage to both human health and the environment due to exposure and the toxicity of these agrochemicals. Sugarcane crops present the highest herbicide consumption, leaving the margins of large watersheds. In this study, we have investigated the occurrence of herbicides in the surface waters of three different catchment areas, the rivers: Tracunhaém, Três Bocas and Capibaribe Mirim, all located in Goiana, Pernambuco, in a region outstanding for its intense agroindustrial activity, coastal marine biome and areas of shrimp farming. These rivers supply the domestic, industrial and agricultural consumption of around 26 municipalities of the North region of the Zona da Mata in the state of Pernambuco, and has a population of 465,549. Twelve herbicides were investigated in the waters of the Goiana River using the ultra-efficient liquid chromatography technique coupled with triploquadrupole mass spectrometry (UPLC-MS/MS). The study was conducted from March to August 2019 and detected the presence of residues from the herbicides Ametryn, Atrazine, Diuron and Tebuthiuron during March, April and May, in concentrations ranging from 10 to 150 µg L-1. The results indicate the need to monitor surface water contamination, as current agricultural practices have an unprecedented impact on water quality and consequently on ecosystems and human health.

20 April 2024 in Clinical Biochemistry
Verified
Journal Article
Closed access
MDMaira Ludna Duarte
Maira Ludna Duarte
ASAurylanne Mikaelle Brandão Silva
Aurylanne Mikaelle Brandão Silva
JSJosé Wellithom Viturino da Silva
José Wellithom Viturino da Silva
DSDavi Pereira Santana
Davi Pereira Santana
WCWhocely Victor De Castro
Whocely Victor De Castro
Leila LealLeila Leal
Leila Leal

24 December 2020 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
PDF file
SCStephanye Carolyne Christino Chagas
Stephanye Carolyne Christino Chagas
FMFrancisca Sueli Monte Moreira
Francisca Sueli Monte Moreira
IBIrla Carla França Barbosa
Irla Carla França Barbosa
OJOsvaldo de Sousa Leal Júnior
Osvaldo de Sousa Leal Júnior
Leila LealLeila Leal
Leila Leal
DSDavi Pereira de Santana
Davi Pereira de Santana
BACKGROUND: The World Health Organization has declared that a pandemic situation exists in relation to the disease caused by the new coronavirus, COVID-19. So far, the absence of a vaccine against the new coronavirus has led people worldwide to seek various therapeutic alternatives, including use of cholecalciferol. DESIGN AND SETTING: Narrative review developed by a research group at a public university in Recife (PE), Brazil. METHODS: We searched the literature on the use of cholecalciferol for prevention or treatment of COVID-19, using the MEDLINE and LILACS databases, with the keywords “vitamin D”, “cholecalciferol”, “SARS-CoV-2”, “COVID-19” and “coronavirus”, from January 1, 2020, to June 10, 2020. Narrative reviews, cohort studies and ecological studies were selected. RESULTS: We retrieved 32 references, of which 8 were considered eligible for intensive review and critical analysis. These comprised five narrative reviews, two observational studies and one protocol proposal. Most of the studies selected reported positive effects from use of vitamin D for prevention or treatment of COVID-19. However, there was little quantitative data to assess the real impact of using this vitamin as an intervention against this disease. CONCLUSIONS: Current studies on vitamin D used for purposes other than bone health promotion cannot be taken as support to justify its use in a disease as recent as COVID-19. Studies of greater robustness, with higher levels of clinical evidence, need to be conducted. Rational use of this vitamin needs to be ensured, thereby minimizing the impacts on the patient and the public healthcare system.

12 December 2025 in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
Verified
Journal Article
Open access
PDF file
Leila LealLeila Leal
Leila Leal
IBIrla Carla de França Barbosa
Irla Carla de França Barbosa
CFCristiano Ferraz
Cristiano Ferraz
DSDavi Pereira de Santana
Davi Pereira de Santana
Introduction: In Brazil, the sale of generic medicines has been increasing, driven by the search for more affordable alternatives. However, this expansion necessitates the assurance of safety and efficacy, particularly in the case of topical medications containing corticosteroids. Until 2022, these products were exempt from bioequivalence testing, with only pharmaceutical equivalence being required. Objective: This study aimed to discuss the registration of topical medications containing corticosteroids in Brazil, highlighting recent regulatory changes and the impact of the mandatory implementation of the Vasoconstrictor Assay (VCA). Method: The methodology consisted of a systematic review of scientific literature and national and international regulatory guidelines, focusing on the registration criteria for topical corticosteroid medications. The study provided a detailed examination of the VCA, a pharmacodynamic test that evaluates the degree of skin blanching following drug application, divided into a pilot study (defining Emax and ED50) and a main study (comparison with the reference product). Results: It was demonstrated that the VCA is widely adopted in international regulatory contexts, such as by the U.S. Food and Drug Administration (FDA) since 1995. In Brazil, its introduction presents a technical challenge, as most bioequivalence centers require appropriate expertise and infrastructure. Nevertheless, studies indicate that the method has the potential to effectively demonstrate bioequivalence. Conclusions: The requirement of the VCA represents a regulatory milestone in Brazil, fostering greater technical rigor in the registration of topical corticosteroid medications. Its adoption is essential to ensure the quality, safety, and efficacy of these products for the population.